VIVO Cannabis Inc (OTCMKTS: VVCIF) elected four directors Eric Shipman, Ray Laflamme, Michael Bumby, and Holly Workman, to its director board in an AGM. AGM is held on July 5, 2021. Michael Bumby is the CFO of Vivo Cannabis, whereas Laflamme is the president and founder of its subsidiary – Canna Farms Limited.
Background of directors
Eric will contribute over 40 years of experience in the advisory role of real estate/ software developers, film producers, financiers, and entrepreneurs. He also got expertise in documenting and negotiating complex commercial transactions and contracts, mergers, and reorganizations. Eric also served as a member of several companies’ boards and audit committees.
Holly worked as a consultant/ contractor for 30 years. She focused on combining transactional OS (operating systems) with their respective corporate counterparts during the previous stints. Laflamme is pleased with the board outcome at today’s AGM. He will be the chair of the board besides the new CEO. Vivo maintains solid relationships and assets in Canada and worldwide. Laflamme is excited about the inclusion of Mike, Holly, and Eric on the director board.
Strives to improve profitability and revenues
The four directors will play an essential role in lowering the costs and improve profitability and revenues. In addition, Vivo would utilize the potential of its teams and assets to ensure fair pricing and offer exemplary customer service.
Appoints new officers
The board appointed Mariana Fonar, Tim Hayden, Carole Chan, and Andreas Sander as General Counsel,
Chief Operations Officer, Chief Commercial/ People Officer, and President (European Operations).
Unveils Beacon Medical Extra Strength CBD T Cream
Vivo Cannabis launched beacon medical extra strength CBD T cream on June 3, 2021. The proprietary formulation – 500 mg CBD in 50 grams comprises carefully selected ingredients possessing analgesic, anti-inflammatory, and antioxidant properties. The innovative cream is designed to relieve symptoms of medical conditions. Vivo Cannabis developed this product under Robert Foldes (President Product Development), in collaboration with topical cannabis formulation, dermatology, and manufacturing companies. Robert is pleased to contribute his R&D experience of topical prescription products to cure various skin ailments. Topical cannabis products provide quick relief for symptoms like inflammation and localized pain.